LIOTONTRAUMA*GEL 40G 2%+5%

Liotontrauma 2%+5% gel
escin + diethylamine salicylate

What it is and what it is used for
Liotontrauma is a medicine for cutaneous (on the skin) use containing the active ingredients escin and diethylamine salicylate used for the treatment of joint and muscle pain resulting from trauma (minor traumatology).

What you need to know before taking the medicine
Do not use Liotontrauma
- if you are allergic to escin and diethylamine salicylate or any of the other ingredients of this medicine (listed in paragraph 6);
- on open lesions (wounds), mucous membranes and skin areas treated with radiation; apply only to intact skin;
- simultaneously in the same area as other topical medicines;
- in children under 12 years of age.
Do not use Liotontrauma for prolonged periods without medical advice.

Warnings and precautions
Talk to your doctor or pharmacist before using Liotontrauma.
There are no risks of addiction (decreased effectiveness) and dependence (the need to continue taking the medicine, more than necessary).
As it is a preparation for local applications, its use must be exclusively external (only on the skin).
The use, especially prolonged, of products for cutaneous use can give rise to allergic phenomena (sensitisation).
Avoid contact of Liotontrauma with the eyes.

Children and adolescents
Liotontrauma should not be used in children under 12 years of age.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In rare cases, allergies (hypersensitivity reactions) such as redness, flaking and dryness (dehydration) of the skin may occur.
This medicine could cause contact dermatitis (allergic inflammation of the skin caused by contact).
Following the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.